Why Is Kodak Making Pharmaceuticals?

PUBLISHED: Sun, 23 Aug 2020 16:00:07 GMT
Share

Last month, the U.S. government announced a letter of interest to provide Kodak with a $765 million loan to launch Kodak Pharmaceuticals. Under this loan, Kodak would manufacture critical pharmaceutical components that have been identified by the FDA as essential but have lapsed into chronic national shortage. But the deal is now on hold as the SEC investigates the circumstances around Kodak’s disclosure of the loan.

» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC TV: ht

Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.